Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A phase III, double-blind, randomized, placebo-controlled, multi-country and multi-center study to assess the efficacy and safety of two doses of GSK Biologicals' oral live attenuated human rotavirus (HRV) vaccine in healthy infants.
Rotavirus Vaccine
107076
NCT00329745
Infections, Rotavirus
Phase 3
 
The results of this study 107076 are summarised with studies 444563/028, 444563/029, 444563/030, 107070, and 107072 on the GSK Clinical Study Register. An annotated case report form is not available for this study. A blank case report form will be provided. A link to Clinicaltrials.gov and a NCT ID number is not available for this study because the study was conducted before regulatory requirements to register studies.
January 2014

Powered by ideaPoint, Inc.